EntryPoint Capital LLC Takes Position in DocGo Inc. (NASDAQ:DCGO)

EntryPoint Capital LLC purchased a new position in DocGo Inc. (NASDAQ:DCGO) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 47,992 shares of the company’s stock, valued at approximately $203,000.

Several other institutional investors and hedge funds have also bought and sold shares of DCGO. Centiva Capital LP purchased a new position in shares of DocGo during the 3rd quarter worth approximately $43,000. Prudential Financial Inc. bought a new stake in shares of DocGo during the fourth quarter valued at approximately $55,000. Royce & Associates LP purchased a new stake in DocGo in the fourth quarter worth $64,000. Intech Investment Management LLC bought a new position in DocGo in the third quarter worth $62,000. Finally, SG Americas Securities LLC lifted its position in DocGo by 12.9% during the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock valued at $183,000 after buying an additional 4,905 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

DocGo Price Performance

DCGO opened at $2.64 on Friday. The firm has a market cap of $269.24 million, a PE ratio of 9.43, a P/E/G ratio of 14.16 and a beta of 1.08. The stock has a 50-day moving average price of $4.03 and a 200-day moving average price of $3.92. DocGo Inc. has a 1 year low of $2.63 and a 1 year high of $5.68.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Stifel Nicolaus reduced their target price on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. Deutsche Bank Aktiengesellschaft cut shares of DocGo from a “buy” rating to a “hold” rating and cut their price objective for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Finally, Needham & Company LLC decreased their target price on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research note on Friday, February 28th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $4.89.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.